Current law prohibits Medicare from covering obesity drugs and gives states flexibility to cover weight loss drugs under Medicaid Limitations on coverage for obesity drugs in Medicare and Medicaid mean that millions of people who have obesity and might benefit from taking GLP-1s may be unable to access them unless they are able to pay the full cash price out of their own pockets, which would likely be prohibitive for people with Medicaid who must have low incomes to qualify for the program, as well as for many people on Medicare with low and modest incomes
Diet and overall health also play a role
How to talk to your doctor about GLP-1 medications Allison Rhodes, MD, an obesity medicine specialist at The Ohio State University Wexner Medical Center, describes how a shared decision-making conversation can go between doctors and patients when it comes to GLP-1 agonist receptor medications for weight loss
BUT, anyone new to the lip flip can relax, knowing that its quite temporary if you just want to try it out with minimum commitment
Health Also, you need to ensure that you are a good candidate for the procedure
.png.jpg)
